Development and Validation of a Risk Score for Mild Cognitive Impairment in Individuals with Type 2 Diabetes in China: A Practical Cognitive Prescreening Tool
Qun Ding,Congcong Yu,Xiang Xu,Yinjiao Hou,Yingwen Miao,Sijue Yang,Shihua Chen,Xuelin Ma,Zhou Zhang,Yan Bi
DOI: https://doi.org/10.2147/dmso.s448321
2024-03-08
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Qun Ding, 1– 4, &ast Congcong Yu, 2, 3, &ast Xiang Xu, 1, 3 Yinjiao Hou, 1, 3 Yingwen Miao, 2, 3 Sijue Yang, 2, 3 Shihua Chen, 2, 3 Xuelin Ma, 2, 3 Zhou Zhang, 2, 3 Yan Bi 1– 3 1 Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, People's Republic of China; 2 Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, People's Republic of China; 3 Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, People's Republic of China; 4 Department of Endocrinology, the Second People's Hospital of Lianyungang, Lianyungang, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zhou Zhang, Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Branch of National Clinical Research Centre for Metabolic Diseases, No. 321, Zhongshan Road, Nanjing, 210008, People's Republic of China, Tel + 86 25-83106666, Email Yan Bi, Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Branch of National Clinical Research Centre for Metabolic Diseases, No. 321, Zhongshan Road, Nanjing, 210008, People's Republic of China, Tel + 86 25-83105313, Email Aim: Numerous evidence suggests that diabetes increases the risk of cognitive impairment. This study aimed to develop and validate a multivariable risk score model to identify mild cognitive impairment (MCI) in patients with type 2 diabetes mellitus (T2DM). Methods: This cross-sectional study included 1256 inpatients (age: 57.5 ± 11.2 years) with T2DM in a tertiary care hospital in China. MCI was diagnosed according to the criteria recommended by the National Institute on Aging-Alzheimer's Association Workgroup, and a MoCA score of 19– 25 indicated MCI. Participants were randomly allocated into the derivation and validation sets at 7:3 ratio. Logistic regression models were used to identify predictors for MCI in the derivation set. A scoring system based on the predictors' beta coefficient was developed. Predictive ability of the risk score was tested by discrimination and calibration methods. Results: Totally 880 (285 with MCI, 32.4%) and 376 (167 with MCI, 33.8%) patients were allocated in the derivation and validation set, respectively. Age, education, HbA 1c , self-reported history of severe hypoglycemia, and microvascular disease were identified as predictors for MCI and constituted the risk score. The AUCs (95% CI) of the risk score were 0.751 (0.717, 0.784) in derivation set and 0.776 (0.727, 0.824) in validation set. The risk score showed good apparent calibration of observed and predicted MCI probabilities and was capable of stratifying individuals into 3 risk categories by two cut-off points (low risk: ≤ 3, medium risk: 4– 13, and high risk ≥ 14). Conclusion: The risk score based on age, education, HbA 1c , self-reported history of severe hypoglycemia, and microvascular disease can effectively assess MCI risk in adults with T2DM at different age. It can serve as a practical prescreening tool for early detection of MCI in daily diabetes care. Keywords: mild cognitive impairment, type 2 diabetes mellitus, risk score, prescreening tool There has been a substantial increase both in the prevalence of diabetes and dementia over the past decades, both of which have become major public health problems. The latest epidemiological evidence shows that there are about 140.9 million adults with diabetes, 1 15.07 million old people with dementia and 38.77 million old people with mild cognitive impairment (MCI) in China. 2 A meta-analysis revealed that diabetes is not only an independent risk factor for MCI and dementia but also promotes the transformation from MCI to dementia. 3 Diabetes-associated cognitive dysfunction as a brain complication of diabetes has attracted much attention. Cognitive dysfunction can affect many aspects of life including diabetes self-management with potentially serious results. 4 There is no effective strategy to treat or revert the process of dementia. MCI, which is a transitional stage between cognitively normal aging and dementia, is possibly modifiable. 5 Therefore, -Abstract Truncated-
endocrinology & metabolism